| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Wolfgang Bäumer | Q53115960 |
| Thierry Olivry | Q40307331 | ||
| P2093 | author name string | Paola Lovato | |
| Britta C Martel | |||
| P2860 | cites work | Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics | Q26799532 |
| Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis | Q27000320 | ||
| Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin | Q27334347 | ||
| Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
| Transgenic mouse technology in skin biology: generation of knockin mice | Q28251230 | ||
| Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis | Q28255158 | ||
| Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments | Q28534767 | ||
| Hyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROS | Q28543509 | ||
| A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis | Q28594608 | ||
| Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects | Q30304511 | ||
| Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens | Q30494794 | ||
| Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice | Q30543593 | ||
| Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis | Q46946155 | ||
| The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis. | Q48327175 | ||
| Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. | Q50686332 | ||
| Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice. | Q51609893 | ||
| Multifocal defects in immune responses in RelB-deficient mice. | Q52525661 | ||
| Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. | Q52540436 | ||
| TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. | Q52608362 | ||
| Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC/Nga mice. | Q52645895 | ||
| Biphasic increase in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga mice. | Q52669500 | ||
| A Mouse Model for Atopic Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903. | Q52930714 | ||
| A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis. | Q53157542 | ||
| Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized Study. | Q53174921 | ||
| Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs | Q44859320 | ||
| Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis | Q44865125 | ||
| Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions | Q44865137 | ||
| Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis | Q44873137 | ||
| TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines. | Q45112454 | ||
| Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition | Q45227623 | ||
| Effects of topical application of Astragalus membranaceus on allergic dermatitis | Q45785953 | ||
| Evaluation of FITC-induced atopic dermatitis-like disease in NC/Nga mice and BALB/c mice using computer-assisted stereological toolbox, a computer-aided morphometric system | Q46121359 | ||
| Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models | Q46317442 | ||
| Induction of thymic stromal lymphopoietin expression in keratinocytes is necessary for generating an atopic dermatitis upon application of the active vitamin D3 analogue MC903 on mouse skin | Q46466229 | ||
| Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice | Q46533710 | ||
| CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. | Q46926239 | ||
| IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation | Q33723349 | ||
| STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis | Q33773485 | ||
| Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. | Q33816405 | ||
| Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions | Q33859449 | ||
| Animal models of atopic dermatitis | Q33915252 | ||
| Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen | Q33915290 | ||
| Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. | Q34006054 | ||
| Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 cells | Q34031692 | ||
| 7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice | Q34109984 | ||
| Fermented fish oil suppresses T helper 1/2 cell response in a mouse model of atopic dermatitis via generation of CD4+CD25+Foxp3+ T cells | Q34370794 | ||
| Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity | Q34384123 | ||
| Immunomodulatory effect of water soluble extract separated from mycelium of Phellinus linteus on experimental atopic dermatitis. | Q34417644 | ||
| Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice | Q34531749 | ||
| Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis | Q34797596 | ||
| Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities | Q35084580 | ||
| Critical role for mast cell Stat5 activity in skin inflammation | Q35087816 | ||
| Species differences in the structure and function of the immune system | Q35128003 | ||
| TSLP is differentially regulated by vitamin D3 and cytokines in human skin | Q35285791 | ||
| Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). | Q35746839 | ||
| Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways | Q35803992 | ||
| Animal models for atopic dermatitis: are they relevant to human disease? | Q35920306 | ||
| Neuroprotection by tetracyclines | Q35941699 | ||
| IL-10 is critical for Th2 responses in a murine model of allergic dermatitis | Q36001280 | ||
| External Application of Apo-9'-fucoxanthinone, Isolated from Sargassum muticum, Suppresses Inflammatory Responses in a Mouse Model of Atopic Dermatitis | Q36001506 | ||
| Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts | Q36125679 | ||
| Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis. | Q36256954 | ||
| Gastrointestinal microbiota and local inflammation during oxazolone-induced dermatitis in BALB/cA mice. | Q36321369 | ||
| Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin | Q36402793 | ||
| Topical application of herbal mixture extract inhibits ovalbumin- or 2,4-dinitrochlorobenzene-induced atopic dermatitis | Q36477969 | ||
| Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice | Q36494915 | ||
| Andrographolide suppresses thymic stromal lymphopoietin in phorbol myristate acetate/calcium ionophore A23187-activated mast cells and 2,4-dinitrofluorobenzene-induced atopic dermatitis-like mice model | Q36617847 | ||
| Heat-Killed Enterococcus faecalis EF-2001 Ameliorates Atopic Dermatitis in a Murine Model | Q36732085 | ||
| TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation | Q36798825 | ||
| Topical Tetracycline Improves MC903-induced Atopic Dermatitis in Mice through Inhibition of Inflammatory Cytokines and Thymic Stromal Lymphopoietin Expression | Q37011376 | ||
| IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. | Q37036021 | ||
| Gender differences in skin: a review of the literature | Q37063787 | ||
| Anti-inflammatory effect of qingpeng ointment in atopic dermatitis-like murine model | Q37147759 | ||
| 7,3',4'-Trihydroxyisoflavone Ameliorates the Development of Dermatophagoides farinae-Induced Atopic Dermatitis in NC/Nga Mice | Q37353339 | ||
| A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. | Q37397800 | ||
| ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis | Q37592298 | ||
| A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. | Q37649820 | ||
| Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis | Q37709681 | ||
| Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. | Q37800572 | ||
| Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers | Q37829424 | ||
| Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice | Q37963808 | ||
| New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity | Q38087729 | ||
| Clinical heterogeneity and differential diagnosis of atopic dermatitis | Q38203591 | ||
| Mechanisms regulating skin immunity and inflammation | Q38203783 | ||
| Animal models for percutaneous absorption | Q38262755 | ||
| Review: Clinical and histological manifestations of canine atopic dermatitis | Q38353279 | ||
| Review: Role of genetics and the environment in the pathogenesis of canine atopic dermatitis. | Q38363734 | ||
| Epicutaneous Allergic Sensitization by Cooperation between Allergen Protease Activity and Mechanical Skin Barrier Damage in Mice. | Q38409130 | ||
| A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae | Q38485154 | ||
| Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and BALB/c | Q38491447 | ||
| Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema. | Q38543872 | ||
| 1,2,4,5-Tetramethoxybenzene Suppresses House Dust Mite-Induced Allergic Inflammation in BALB/c Mice | Q38761003 | ||
| The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization | Q38957597 | ||
| Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling | Q39323642 | ||
| Pharmacology and toxicology of doxycycline | Q39538901 | ||
| Resveratrol ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium | Q39969104 | ||
| S2k guideline on diagnosis and treatment of atopic dermatitis--short version | Q40162268 | ||
| Atopic dermatitis: triggering factors. | Q40697922 | ||
| Mixture of Polyphenols and Anthocyanins from Vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice | Q41568932 | ||
| Transgenic mouse technology in skin biology: inducible gene knockout in mice | Q42210726 | ||
| Spontaneous atopic dermatitis-like symptoms in a/a ma ft/ma ft/J flaky tail mice appear early after birth | Q42859520 | ||
| Pharmacological characterization of itch-associated response induced by repeated application of oxazolone in mice | Q42994022 | ||
| Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling | Q43183078 | ||
| Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment | Q44240143 | ||
| AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis. | Q44574226 | ||
| Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis. | Q44858410 | ||
| Immunosuppressive effects of fisetin against dinitrofluorobenzene-induced atopic dermatitis-like symptoms in NC/Nga mice. | Q53295647 | ||
| Overexpression of cathepsin S induces chronic atopic dermatitis in mice. | Q53394664 | ||
| Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice. | Q53428512 | ||
| An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases. | Q53532960 | ||
| Effects of topically applied rapamycin and mycophenolic acid on TNCB-induced atopic dermatitis-like skin lesions in NC/Nga mice. | Q53575360 | ||
| Epicutaneous sensitization with superantigen induces allergic skin inflammation. | Q54265045 | ||
| A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. | Q55052634 | ||
| Functional polysaccharides from Grifola frondosa aqueous extract inhibit atopic dermatitis-like skin lesions in NC/Nga mice | Q57221694 | ||
| Lack of preventing effect of systemically and topically administered histamine H1 or H4 receptor antagonists in a dog model of acute atopic dermatitis | Q57435627 | ||
| The Effect of Occlusion on Epidermal Penetration of Parabens from a Commercial Allergy Test Ointment, Acetone and Ethanol Vehicles | Q59524408 | ||
| Repeated epicutaneous exposures to ovalbumin progressively induce atopic dermatitis-like skin lesions in mice | Q60812039 | ||
| Topical Superantigen Exposure Induces Epidermal Accumulation of CD8+ T Cells, a Mixed Th1/Th2-Type Dermatitis and Vigorous Production of IgE Antibodies in the Murine Model of Atopic Dermatitis | Q61473209 | ||
| Increased number of immunoreactive nerve fibers in atopic dermatitis | Q67543526 | ||
| In vivo expression of IL-12 and IL-13 in atopic dermatitis | Q71423348 | ||
| Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells | Q73149166 | ||
| Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris | Q73307513 | ||
| An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis | Q73431465 | ||
| Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse | Q73507976 | ||
| A major determinant quantitative-trait locus responsible for atopic dermatitis-like skin lesions in NC/Nga mice is located on Chromosome 9 | Q73654187 | ||
| Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice | Q78197539 | ||
| Translation of research evidence from animals to humans | Q79220569 | ||
| A new chronic itch model accompanied by skin lesions in hairless mice | Q80140105 | ||
| Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model | Q81009296 | ||
| Scratching of their skin by NC/Nga mice leads to development of dermatitis | Q81101491 | ||
| Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis | Q81283354 | ||
| The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model | Q81301920 | ||
| Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs | Q82259559 | ||
| Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles | Q82723377 | ||
| Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis | Q82809770 | ||
| Environmental and oral challenge with storage mites in beagles experimentally sensitized to Dermatophagoides farinae | Q83057044 | ||
| Simultaneous sensitivity to fragrances | Q83193315 | ||
| Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice | Q83523130 | ||
| Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice | Q83627641 | ||
| CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model | Q83876799 | ||
| CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis | Q84002804 | ||
| Histamine H(4) receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model | Q84336685 | ||
| Affinity purification of egg-white allergens for improved component-resolved diagnostics | Q84600223 | ||
| Anthocyanins, but not anthocyanidins, from bilberry (Vaccinium myrtillus L.) alleviate pruritus via inhibition of mast cell degranulation | Q85483004 | ||
| Atopic dermatitis | Q86174273 | ||
| The Hot-Water Extract of Smilacis Chinae Rhizome Suppresses 2,4-Dinitrochlorobenzene and House Dust Mite-Induced Atopic Dermatitis-Like Skin Lesions in Mice | Q87219152 | ||
| Dupilumab treatment in adults with moderate-to-severe atopic dermatitis | Q87371931 | ||
| Inhibitory effects of Solanum tuberosum L. var. vitelotte extract on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice | Q88146844 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | atopic dermatitis | Q268667 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 389-402 | |
| P577 | publication date | 2017-09-01 | |
| 2017-09-25 | |||
| P1433 | published in | Yale Journal of Biology and Medicine | Q15709982 |
| P1476 | title | Translational Animal Models of Atopic Dermatitis for Preclinical Studies. | |
| P478 | volume | 90 |
| Q90713975 | 3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models |
| Q55080639 | Antipruritic Effects of Botulinum Neurotoxins. |
| Q90394731 | Calcium imaging of primary canine sensory neurons: Small-diameter neurons responsive to pruritogens and algogens |
| Q55517994 | Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model. |
| Q58790084 | Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease |
| Q83226396 | Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis |
| Q93348265 | Recent Advances in Body-on-a-Chip Systems |
Search more.